---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-020830"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:21:01.542801+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharmaceuticals to acquire United Dogecoin, becomes public Dogecoin miner with $11M PIPE

## Summary
- Merger consideration: 8,000 Series B-1 preferred shares convertible into ~32.3M common shares at $1.24 per share.
- Concurrent $11M PIPE via Series B-2 convertible preferred and warrants; conversion price $1.03 per share.
- United Dogecoin plans 3,000 ElphaPex mining rigs; targets 43,200 GH/s (~1.5% of global Dogecoin hash rate).
- Ryan Trasolini (United Dogecoin CEO) to become co-CEO of combined company; closing expected May 4, 2026.

## SEC filing metadata
- accession: 0001493152-26-020830
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315226020830/0001493152-26-020830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315226020830/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-020830
- JSON: https://secwatch.observer/filing/0001493152-26-020830.json
- Plain text: https://secwatch.observer/filing/0001493152-26-020830.txt

## Source-grounded claims
- claim_id: 6da052a923a2d3129507515cc0899a613af79cbc
  claim: Shuttle Pharmaceuticals Holdings, Inc. entered into Agreement and Plan of Merger with United Dogecoin Inc. valued at Merger consideration consisting of Series B-1 convertible preferred stock and up to 118,038,551 pre- (effective 2026-04-30).
  evidence_excerpt: On April 30, 2026, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315226020830/0001493152-26-020830-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.